Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

hMaxi-K gene transfer for erectile dysfunction safe in phase I study

April 27, 2006

SUNRISE study reveals urinary urgency improvement with solifenacin

April 27, 2006

Tolterodine improves overactive bladder symptoms and patient quality of life

April 27, 2006

Pfizer announces new tolterodine study and releases data on overactive bladder prevalence

April 26, 2006

Urinary incontinence improved by cizolirtine in overactive bladder patients

April 26, 2006

Fesoterodine superior to tolterodine in overactive bladder trial

April 26, 2006

No serious side effects in ongoing phase II study of NX-1207

April 26, 2006

Detrusitol receives Japanese approval for overactive bladder

April 25, 2006

ILY-101 completes phase I trial for hyperphosphatemia

April 25, 2006

Novel agent for the management of acute renal failure in sepsis

April 24, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...